Magnetic resonance imaging-guided delivery of adeno-associated virus type 2 to the primate brain for the treatment of lysosomal storage disorders.
about
Gene-based therapy of Parkinson's Disease: Translation from animal model to human clinical trial employing convection enhanced deliveryA Unilateral Cervical Spinal Cord Contusion Injury Model in Non-Human Primates (Macaca mulatta).Rapid inverse planning for pressure-driven drug infusions in the brainGene transfer corrects acute GM2 gangliosidosis--potential therapeutic contribution of perivascular enzyme flowGuided delivery of adeno-associated viral vectors into the primate brainReal-time MR imaging with Gadoteridol predicts distribution of transgenes after convection-enhanced delivery of AAV2 vectorsEvaluation of an AAV2-based rapamycin-regulated glial cell line-derived neurotrophic factor (GDNF) expression vector system.Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's diseaseLentiviral-mediated gene transfer to the sheep brain: implications for gene therapy in Batten disease.Safety study of adeno-associated virus serotype 2-mediated human acid sphingomyelinase expression in the nonhuman primate brain.Merits of combination cortical, subcortical, and cerebellar injections for the treatment of Niemann-Pick disease type AGene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.Genetic therapy for the nervous system.Gene therapy for the neurological manifestations in lysosomal storage disorders.Optogenetic Approaches for Controlling Seizure Activity.Anterograde axonal transport of AAV2-GDNF in rat basal gangliaImaging of Convective Drug Delivery in the Nervous System.MR-guided delivery of AAV2-BDNF into the entorhinal cortex of non-human primates.
P2860
Q26851517-14ABD387-DB0A-4AC7-83E6-99096ADBF7D1Q27307173-45CA26FD-2796-4199-AA9F-A4DF69C62141Q28486200-1FB2F1A2-CD37-4A5C-BBF0-4F83AF60E3E7Q30523995-3F1853F9-C618-49A9-A79E-E83C7F3F6550Q34061373-1A347F78-0655-40FA-83A4-66F4F845238AQ34080874-15AF479F-E351-4E6D-A83E-EF92F5594500Q34087812-5B0819BF-FADD-41A9-BC1C-D8876F3E887EQ35086686-DFFA2FFA-0E62-411F-A11E-FE5B37DC2C7DQ35174910-0EE7C2CC-BED1-472A-9F19-0138C4261CCEQ36147515-F3B30B81-9594-45DE-89B8-E84A8005F4E1Q36299764-4FFFCDB1-D11C-4A12-9EDC-A30688B1BD83Q37127238-25FA8BCF-DD3A-4095-8291-DD933B57482EQ37856565-85EE236B-CE72-4B4F-BC35-50BC307DB38BQ38200599-0EA09FDD-F669-455A-800F-0B01B07080C6Q38834011-69D9D117-5DEE-409B-8BED-EB667266D388Q39628466-E2C324F2-5576-4C65-8198-6A7724552B7AQ50059251-DF6014AB-321A-4676-AAFB-6108F74CA52EQ52356936-4FAC0121-363F-4A0A-A406-D22A63264860
P2860
Magnetic resonance imaging-guided delivery of adeno-associated virus type 2 to the primate brain for the treatment of lysosomal storage disorders.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Magnetic resonance imaging-gui ...... f lysosomal storage disorders.
@en
Magnetic resonance imaging-gui ...... f lysosomal storage disorders.
@nl
type
label
Magnetic resonance imaging-gui ...... f lysosomal storage disorders.
@en
Magnetic resonance imaging-gui ...... f lysosomal storage disorders.
@nl
prefLabel
Magnetic resonance imaging-gui ...... f lysosomal storage disorders.
@en
Magnetic resonance imaging-gui ...... f lysosomal storage disorders.
@nl
P2093
P2860
P356
P1433
P1476
Magnetic resonance imaging-gui ...... f lysosomal storage disorders.
@en
P2093
E Aguilar Salegio
J Forsayeth
K S Bankiewicz
L S Shihabuddin
M A Passini
M S Fiandaca
P Hadaczek
R M Richardson
P2860
P304
P356
10.1089/HUM.2010.040
P577
2010-09-01T00:00:00Z